Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
129 USD | -0.78% | +1.21% | +18.43% |
03:02pm | Merck: phase 3 trial in melanoma halted | CF |
02:05pm | Merck Ends Co-Formulation Arm of Keytruda High-Risk Melanoma Study | DJ |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.